Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Open-market buy CEO bought 150,000 shares at an average $0.40 ($59,295)
  2. 4 Open-market buy Chief R&D Officer bought 10,000 shares at $0.39 ($3,900)
  3. 4 Exercise or conversion Dir. of Operations, Secretary acquired 21,900 shares (option exercise)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 25,000 shares at $0.40 ($10,000)
  16. 4 Open-market buy Controller/Prin Fin&Acct Offic bought 4,283 shares at $0.40 ($1,703)
  17. 4 Open-market buy COO, CSO bought 10,000 shares at $0.40 ($4,000)
  18. 4 Open-market buy Controller/Prin Fin&Acct Offic bought 2,452 shares at $0.41 ($1,005)
  19. 4 Open-market buy Interim CEO bought 130,000 shares at an average $0.40 ($51,731)
  20. 4 Open-market buy Director bought 30,000 shares at $0.43 ($12,900)

Page 8 of 17 · 339 filings